Structural insights into Plasmodium PPIases

Area of Science:

• Parasitology
• Structural Biology
• Drug Discovery

Background:

• Malaria remains a significant global health challenge, exacerbated by drug-resistant Plasmodium falciparum strains.
• Novel antimalarial drug targets are urgently needed to combat resistance.
• A chemo-genomics approach can identify new drug targets and mechanisms of action.

Purpose of the Study:

• To review structural insights into Plasmodium Peptidyl prolyl cis/trans isomerases (PPIases).
• To explore PPIases as potential antimalarial drug targets.
• To summarize perspectives on drug discovery targeting Plasmodium PPIases.

Main Methods:

• Identification and structural characterization of Plasmodium PPIases (cyclophilins and FK506-binding proteins).
• Analysis of inhibitor complexes with Plasmodium PPIases.
• Review of previous studies on targeting Plasmodium FKBP35 with non-immunosuppressive drugs.

Main Results:

• Plasmodium parasites contain PPIases, which are targets of immunosuppressive drugs like cyclosporin A, FK506, and rapamycin.
• Structural data on Plasmodium PPIases and their inhibitor complexes have been generated.
• Non-immunosuppressive drugs targeting FKBP35 have been investigated.

Conclusions:

• Plasmodium PPIases represent promising targets for novel antimalarial drug development.
• Structural information is crucial for designing effective inhibitors.
• Further research into PPIase inhibitors could lead to new therapeutic strategies against malaria.